Yuhan & CKD smile in 3rd quarter’s performance among Big 5 pharmas

Published: 2016-10-19 14:05:07

Updated: 2016-10-19 14:05:07

It was analyzed the Big 5 pharmaceutical companies had different performances in sales in the 3^rd quarter.

While Yuhan Corporation and Chong Kun Dang(CKD) recorded decent performances, Hanmi Pharm, Green Cross and Dong-A ST are expected to have poor records.

Yuanta Securities Korea analyzed the result of the Big 5 pharmaceutical companies, including Yuhan Corporation, Green Cross, Hanmi Pharm...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.